PAYER POLICY CHANGES

J9217 Insurance Policy Changes

HCPCS J9217 is officially defined as "Leuprolide acetate (for depot suspension), 7.5 mg." HCPCS J9217 is referenced in 27 tracked payer policy changes from BCBS Tennessee, Independence Blue Cross, and 8 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9217 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J9217

Get one email when a payer policy names J9217, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J9217

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J9217 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.